PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24148808-5	2014	Peripheral subcutaneous injections of AEA, 2-AG, WIN55,212-2 (WIN; a CB1/CB2 synthetic agonist), URB597 and URB602 significantly decreased mechanical allodynia and thermal hyperalgesia.	aea	38-41	cannabinoid receptor 2 (macrophage)	Mus musculus	73-76	
24148808-3	2014	Several recent studies examining the contribution of CB1 and/or CB2 receptors on the peripheral antinociceptive effects of AEA, 2-AG, URB597 and URB602 in neuropathic pain conditions using either pharmacological tools or transgenic mice separately have been reported, but the exact mechanism is still uncertain.	aea	123-126	cannabinoid receptor 2 (macrophage)	Mus musculus	64-67	
17259073-3	2007	Anandamide (N-arachidonoylethanolamine) and 2-AG (2-arachidonoylglycerol) are two major endocannabinoids that bind to and activate G-protein coupled cannabinoid receptors CB1 and CB2.	aea	12-38	cannabinoid receptor 2 (macrophage)	Mus musculus	179-182	
12137909-1	2002	Anandamide (N-arachidonoylethanolamine), an arachidonic acid derivative, is an endogenous ligand for both the brain-type (CB1-R) and spleen-type (CB2-R) cannabinoid receptors.	aea	12-38	cannabinoid receptor 2 (macrophage)	Mus musculus	146-151